117 related articles for article (PubMed ID: 35511648)
1. [ALK-HOOK1-rearranged renal cell carcinoma: report of a case].
Xu AD; Fu Y; Zhao XS; Fan X
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):464-466. PubMed ID: 35511648
[TBL] [Abstract][Full Text] [Related]
2. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
[TBL] [Abstract][Full Text] [Related]
3. ALK-rearranged renal cell carcinomas in Polish population.
Gorczynski A; Czapiewski P; Korwat A; Budynko L; Prelowska M; Okon K; Biernat W
Pathol Res Pract; 2019 Dec; 215(12):152669. PubMed ID: 31677810
[TBL] [Abstract][Full Text] [Related]
4.
Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
[TBL] [Abstract][Full Text] [Related]
5. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
[TBL] [Abstract][Full Text] [Related]
6. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
Hang JF; Chung HJ; Pan CC
Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
[TBL] [Abstract][Full Text] [Related]
7. [STRN::ALK fusion renal cell carcinoma with lung metastasis: report of a case].
Xian J; Yin XX; Wang DH; Zhang MX; Zheng LM; Zhou Q; Chen N
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):631-633. PubMed ID: 38825915
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
Matsuura Y; Ninomiya H; Ichinose J; Nakao M; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):441-451.e1. PubMed ID: 33131892
[TBL] [Abstract][Full Text] [Related]
9. Dramatic response to alectinib in a patient with ALK-rearranged squamous cell lung cancer.
Shiihara J; Ohyanagi F; Amari H; Toda M; Tahara H; Yuzawa M; Maeda Y; Nomura M; Mizushina Y; Nagai Y; Ohta H; Yamaguchi Y
Thorac Cancer; 2021 Sep; 12(17):2420-2423. PubMed ID: 34324792
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.
Wang XT; Fang R; Ye SB; Zhang RS; Li R; Wang X; Ji RH; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
Pathol Res Pract; 2019 Nov; 215(11):152651. PubMed ID: 31563285
[TBL] [Abstract][Full Text] [Related]
11. Case Report: A Case Report of a Histological Transformation of
Zhang Y; Qin Y; Xu H; Yao Q; Gao Y; Feng Y; Ren J
Pathol Oncol Res; 2021; 27():637745. PubMed ID: 34257603
[TBL] [Abstract][Full Text] [Related]
12. Melanoregulin-Anaplastic Lymphoma Kinase (ALK), a Novel ALK Rearrangement That Responds to Crizotinib in Lung Adenocarcinoma.
Wang L; Yao S; Teng L; Zhang W; Chen L
J Thorac Oncol; 2020 Mar; 15(3):e44-e46. PubMed ID: 32093861
[No Abstract] [Full Text] [Related]
13. Superficial ALK-rearranged myxoid spindle cell neoplasm with a novel FMR1-ALK fusion gene.
Kao YC; Lee PH; Wu CL; Yu SC; Huang HY
Mod Pathol; 2022 Mar; 35(3):438-441. PubMed ID: 34937902
[No Abstract] [Full Text] [Related]
14. Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer.
Wang W; Sun X; Hui Z
Oncol Res Treat; 2019; 42(11):599-606. PubMed ID: 31527380
[TBL] [Abstract][Full Text] [Related]
15. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
[TBL] [Abstract][Full Text] [Related]
16. Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript.
Cajaiba MM; Jennings LJ; George D; Perlman EJ
Genes Chromosomes Cancer; 2016 Oct; 55(10):814-7. PubMed ID: 27225638
[No Abstract] [Full Text] [Related]
17. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
[No Abstract] [Full Text] [Related]
18. Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.
Iannantuono GM; Riondino S; Sganga S; Roselli M; Torino F
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409355
[TBL] [Abstract][Full Text] [Related]
19. Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
Mendoza DP; Stowell J; Muzikansky A; Shepard JO; Shaw AT; Digumarthy SR
Clin Lung Cancer; 2019 Sep; 20(5):339-349. PubMed ID: 31164317
[TBL] [Abstract][Full Text] [Related]
20. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.
Chen W; Li W; Bai B; Wei H
Oncol Rep; 2020 Mar; 43(3):817-826. PubMed ID: 32020234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]